Gomez G, et al. - Researchers sought to apply various cost models in different clinical environments to ascertain the most cost-effective way to prescribe ear drops after tympanostomy tube insertion. An effort ought to be made by the otolaryngologists to become familiar with the cost of ototopical medications and the significant variability between inpatient and outpatient settings. Whenever possible, the cost of ototopical agents ought to be shifted to the institution's outpatient pharmacy whenever possible especially for branded, higher cost combination drops. Experts suggested the basis of the treatment to be the status of the patients' ear disease at the time of middle tube insertion.